AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
75 hedge funds and large institutions have $354M invested in Akcea Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 7 closing their positions.
Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
26
Reduced
19
Closed
7
Calls
$1.98M
Puts
$3.18M
Net Calls
-$1.2M
Net Calls Change
+$260K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$4.91M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$4.29M |
| 3 |
3
Squarepoint
New York
|
$2.44M |
| 4 |
4
D.E. Shaw & Co
New York
|
$2.83M |
| 5 |
5
Millennium Management
New York
|
$1.4M |
